Treatment of laryngopharyngeal and lingual hereditary angioedema with bradykinin-B2-receptor-antagonist icatibant

被引：0
|
作者：
Bas, M.
Greve, J.
Kojda, G.
Bier, H.
Hoffmann, K.
机构：
[1] Univ Hosp Dusseldorf, Dusseldorf, Germany
[2] Univ Hosp Dusseldorf, Inst Pharmacol & Clin Pharmacol, Dusseldorf, Germany
来源：
ALLERGY | 2007年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：95 / 95
页数：1
相关论文
共 50 条
  • [41] Icatibant for the Treatment of Hereditary Angioedema
    Cole, Sabrina W.
    Lundquist, Lisa M.
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (01) : 49 - 55
  • [42] Icatibant for the treatment of hereditary angioedema
    Kalra, Neelu
    Craig, Timothy
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (07): : 743 - 750
  • [43] Treatment of idiopathic angio-edema with Icatibant, a bradykinin B2 receptor antagonist
    Bork, K.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2009, 7 : 177 - 177
  • [44] TREATMENT OF 340 HEREDITARY ANGIOEDEMA ATTACKS WITH ICATIBANT, A BRADYKININ B2 RECEPTOR ANTAGONIST, DURING THE OPEN-LABEL EXTENSION PHASE OF THE FAST-1 CLINICAL TRIAL
    Riedl, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2009, 103 (05) : A113 - A113
  • [45] Icatibant, a Selective Bradykinin-B2 Receptor Antagonist, in Acquired Angioedema Due to C1 Inhibitor Deficiency
    Bork, K.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 127 (02) : AB100 - AB100
  • [46] PHA-022121: A Novel and Potent Bradykinin 2 Receptor Antagonist for Oral Treatment of Hereditary Angioedema
    Crabbe, Raf
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2021, 147 (02) : AB242 - AB242
  • [47] Succesful treatment with icatibant for hereditary angioedema
    Almero, R.
    Campos, A.
    Monte, E.
    Diaz, M.
    Calaforra, S.
    Hernandez, D.
    ALLERGY, 2010, 65 : 600 - 601
  • [48] The role of icatibant-the B2 bradykinin receptor antagonist-in life-threatening laryngeal angioedema in the ED
    Bartal, Carmi
    Zeldetz, Vladimir
    Stavi, Vered
    Barski, Leonid
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2015, 33 (03): : 479.e1 - 479.e3
  • [49] The effectiveness of Icatibant in the treatment of hereditary angioedema
    Frambach, Y.
    Schumacher, N.
    Grabbe, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2008, 6 (10): : 915 - 915
  • [50] Icatibant, an inhibitor of bradykinin receptor 2, for hereditary angioedema attacks: prospective experimental single-cohort study
    Campos, Regis Albuquerque
    Rodrigues Valle, Solange Oliveira
    Franca, Alfeu Tavares
    Cordeiro, Elisabete
    Serpa, Faradiba Sarquis
    Mello, Yara Ferreira
    Malheiros, Teresinha
    Toledo, Eliana
    Mansour, Elie
    Fusaro, Gustavo
    Grumach, Anete Sevciovic
    SAO PAULO MEDICAL JOURNAL, 2014, 132 (05): : 261 - 265
12345